Pulmonx Corp — Director's Dealing 2021

Jun 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-06-01

Reporting Person: French Glendon E. III (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-01	Common Stock	A	45600	$0.00	Acquired	1247984	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Employee Stock Option (right to buy)	$43.40	A	103700	Acquired	2031-05-31	Common Stock (103700)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	26571	Indirect

Footnotes

F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021.

F2: Includes 2,500 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 24, 2021.

F3: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee.

F4: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021.